Publications | Lund University Publications

1 – 3 of 3

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/publication?embed=1&q=author%3D%22Sundberg%2C+Annika%22+or+(documentType+any+%22bookEditor+conferenceEditor%22+and+editor%3D%22Sundberg%2C+Annika%22)&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

2015
Mark A phase 1 dose-escalation study of antibody BI-505 in relapsed/refractory multiple myeloma.
Hansson, Markus ^LU ; Gimsing, Peter ; Badros, Ashraf Z ; Martinsson Niskanen, Titti ; Nahi, Hareth ; Offner, Fritz ; Salomo, Morten ; Sonesson, Elisabeth ; Mau-Sorensen, Morten and Stenberg, Yvonne , et al. (2015) In Clinical Cancer Research 21(12). p.2730-2736
- Contribution to journal › Article
Mark Antagonistic Human FcγRIIB (CD32B) Antibodies Have Anti-Tumor Activity and Overcome Resistance to Antibody Therapy In Vivo.
Roghanian, Ali ; Teige, Ingrid ^LU ; Mårtensson, Linda ^LU ; Cox, Kerry L ; Kovacek, Mathilda ^LU ; Ljungars, Anne ; Mattson, Jenny ^LU ; Sundberg, Annika ; Vaughan, Andrew T and Shah, Vallari , et al. (2015) In Cancer Cell 27(4). p.473-488
- Contribution to journal › Article
2013
Mark A human icam-1 antibody isolated by a function-first approach has potent macrophage-dependent antimyeloma activity in vivo.
Veitonmäki, Niina ; Hansson, Markus ^LU ; Zhan, Fenghuang ; Sundberg, Annika ; Löfstedt, Tobias ^LU ; Ljungars, Anne ; Li, Zhan-Chun ; Martinsson-Niskanen, Titti ; Zeng, Ming and Yang, Ye , et al. (2013) In Cancer Cell 23(4). p.502-515
- Contribution to journal › Article

your query:: Remove author: Sundberg, Annika